[SIDE-EFFECTS IN THE ORAL TREATMENT OF DIABETES WITH SULFONYLUREAS].
D000740:Anemia; D000741:Anemia, Aplastic; D001855:Bone Marrow Diseases; D002271:Carbutamide; D002747:Chlorpropamide; D003920:Diabetes Mellitus; D007003:Hypoglycemia; D007004:Hypoglycemic Agents; D007565:Jaundice; D041781:Jaundice, Obstructive; D008107:Liver Diseases; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D014116:Toxicology
D007004:Hypoglycemic Agents; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D002271:Carbutamide; D002747:Chlorpropamide
ANEMIA, APLASTIC; ANTIDIABETICS; BONE MARROW DISEASES; CARBUTAMIDE; CHLORPROPAMIDE; HYPOGLYCEMIA; JAUNDICE, OBSTRUCTIVE; LIVER DISEASES; REVIEW; TOLBUTAMIDE; TOXICOLOGIC REPORT
BIVERKNINGAR VID ORAL DIABETESBEHANDLING MED SULFONYLUREA.